Term ended Jul 15, 2025 · High confidence
20-year base term ended Jul 15, 2025
Held by Curia Global, Inc.
Filed Jun 12, 2015 as application 14/737,897 · Granted Nov 22, 2016
Base term, 20 years from filing
Today
Term ended Jul 15, 2025
2005
2026
Clock starts
Jul 15, 2005
Jul 15, 2005
Term ended
Jul 15, 2025
Jul 15, 2025
Granted
Nov 22, 2016
Nov 22, 2016
base term
after the term ends
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jul 15, 2005, when application 11/183,066, the earliest non-provisional in its chain, was filed (this one was filed Jun 12, 2015) | Jul 15, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 2 of 2 maintenance fees paid | term ended | High confidence |
| Computed term end | The steps above, in order | Jul 15, 2025 | High confidence |
This family
| US 7,541,357 | Term ended Nov 2026 | Nov 2026 |
| US 8,227,486 | Term ended Nov 2026 | Nov 2026 |
| US 8,236,796 | Term ended Nov 2026 | Nov 2026 |
| US 8,741,901 | Term ended Jul 2025 | Jul 2025 |
| US 9,085,531 | Term ended no later than Jul 2025 | no later than Jul 2025 |
| US 9,499,531 | this patent Jul 2025 | Jul 2025 |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 5, 2015 Reel 36257, frame 914 | Albany Molecular Research, Inc.; Amri Ssci, LLC | Barclays Bank PLC, as the Collateral Agent | Security Interest |
| Jun 22, 2016 Reel 39116, frame 827 | Bristol-Myers Squibb Company | Albany Molecular Research, Inc. | Assignment of Assignor's Interest |
| Aug 31, 2017 Reel 43742, frame 85 | Barclays Bank PLC, as Collateral Agent | Albany Molecular Research, Inc.; Alo Acquisition LLC; Amri Burlington, Inc.; Amri Rensselaer, Inc.; Cedarburg Pharmaceuticals, Inc.; Oso Biopharmaceuticals Manufacturing, LLC; Amri Ssci, LLC; Euticals Inc. | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Albany Molecular Research, Inc. | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Alo Acquisition LLC | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Amri Burlington, Inc. | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Amri Rensselaer, Inc. | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Cedarburg Pharmaceuticals, Inc. | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Oso Biopharmaceuticals Manufacturing, LLC | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Amri Ssci, LLC | Release of Security Interest |
| Aug 31, 2017 reel/frame not recorded | Barclays Bank PLC, as Collateral Agent | Euticals Inc. | Release of Security Interest |
| Sep 1, 2017 Reel 43746, frame 621 | Albany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing, LLC-by Its Sole Member: Alo Acquisition LLC | Barclays Bank, PLC as Collateral Agent | First Lien Security Agreement |
| Sep 1, 2017 Reel 43746, frame 657 | Albany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing LLC-by Its Sole Member:alo Acquisition LLC | Morgan Stanley Senior Funding, Inc. | Second Lien Security Agreement |
| Oct 29, 2020 Reel 54252, frame 687 | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Albany Molecular Research, Inc.; Amri Burlington, Inc.; Cedarburg Pharmaceuticals, Inc.; Euticals Inc.; Oso Biopharmaceuticals Manufacturing, LLC | Release of Security Interest |
| Oct 29, 2020 reel/frame not recorded | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Albany Molecular Research, Inc. | Release of Security Interest |
| Oct 29, 2020 reel/frame not recorded | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Amri Burlington, Inc. | Release of Security Interest |
| Oct 29, 2020 reel/frame not recorded | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Cedarburg Pharmaceuticals, Inc. | Release of Security Interest |
| Oct 29, 2020 reel/frame not recorded | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Euticals Inc. | Release of Security Interest |
| Oct 29, 2020 reel/frame not recorded | Morgan Stanley Senior Funding, Inc., as Collateral Agent | Oso Biopharmaceuticals Manufacturing, LLC | Release of Security Interest |
| Nov 16, 2020 Reel 54382, frame 326 | Barclays Bank PLC, as Collateral Agent | Albany Molecular Research, Inc. | Release of Security Interest |
| Mar 7, 2025 Reel 70442, frame 908 | Curia Global, Inc.; Curia IP Holdings, LLC; Curia Bio, Inc. | Apollo Administrative Agency LLC | Security Interest |
| May 20, 2025 Reel 71298, frame 97 | Albany Molecular Research, Inc. | Curia Global, Inc. | Change of Name |
| Jun 3, 2025 Reel 71490, frame 880 | Apollo Administrative Agency LLC | Curia Global, Inc. | Partial Release of First Lien Intellectual Property Security Agreement Supplement |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2016 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.